Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Omura (Quebec city, Canada), K. Habbout (Quebec city, Canada), S. Martineau (Quebec city, Canada), S. Breuils-Bonnet (Quebec city, Canada), V. Nadeau (Quebec city, Canada), F. Potus (Kingston, Canada), S. L. Archer (Kingston, Canada), R. Paulin (Quebec city, Canada), S. Provencher (Quebec city, Canada), O. Boucherat (Quebec city, Canada), S. Bonnet (Quebec city, Canada). Long Non-coding RNA H19 in Right Ventricular Failure associated with Pulmonary Arterial Hypertension. 5040

Member's Comments

No comment yet.

Related content which might interest you: Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Supraventricular Arrhythmias in Pulmonary Arterial Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Right Ventricular Failure in an Animal Model of Severe Pulmonary Arterial Hypertension: eNOS Uncoupling and Protein Kinase G Signaling in the Transition from Adaptive to Maladaptive Remodeling Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Implication of Enhancer of Zeste Homolog 2 in Pulmonary Arterial Hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Contribution of BMP9 to Pulmonary Arterial Hypertension Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension Year: 2017 Role of CHK1 in Pulmonary Arterial Hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Myocardial metabolic changes in experimental non-hypertrophied and hypertrophied right ventricular failure Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009 Effects of Long Term Exogenous Apelin Application in Experimental Pulmonary Hypertension Model Created with Monocrotaline Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Liquid biopsy for Chronic Thromboembolic Pulmonary Hypertension: Circulating microRNA profile by Next Generation Sequencing Source: International Congress 2017 – PAH and CTEPH Year: 2017 Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017